Effects of Royal Jelly Peptide on Motor Ability and Gene Expression in Zebrafish Model of Alzheimer's Disease
Objective: Investigation of the trait improvement impact of royal jelly enzymatic products (royal jelly peptides) on Alzheimer's disease (AD) model zebrafishes. Methods: 150 wild-type AB strain zebrafishes (4 days after fertilization, 4 dpf) were randomly divided into normal group, model contro...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
The editorial department of Science and Technology of Food Industry
2023-11-01
|
| Series: | Shipin gongye ke-ji |
| Subjects: | |
| Online Access: | http://www.spgykj.com/cn/article/doi/10.13386/j.issn1002-0306.2023010021 |
| _version_ | 1797650356661911552 |
|---|---|
| author | Juncai LIU Zhen GE Xiao JIANG Baojin CUI Ping ZHANG Jian'an SUN Xiangzhao MAO |
| author_facet | Juncai LIU Zhen GE Xiao JIANG Baojin CUI Ping ZHANG Jian'an SUN Xiangzhao MAO |
| author_sort | Juncai LIU |
| collection | DOAJ |
| description | Objective: Investigation of the trait improvement impact of royal jelly enzymatic products (royal jelly peptides) on Alzheimer's disease (AD) model zebrafishes. Methods: 150 wild-type AB strain zebrafishes (4 days after fertilization, 4 dpf) were randomly divided into normal group, model control group, donepezil hydrochloride positive control group (3.33 μg/mL), royal jelly enzymatic digest lyophilized powder-1 group (LPR-1, 1000 μg/mL) and royal jelly enzymatic digest lyophilized powder-2 group (LPR-2, 1000 μg/mL), and these groups were added in 6-well plates, respectively. The volume of each well was 3 mL, and 30 tails of zebrafishes were employed in each group. Except for the normal group, zebrafishes in other groups were treated with aluminum chloride hexahydrate (180 μmol/L) to establish AD models. The efficacy of recovery of motor dysfunction, improvement of responsiveness, inhibition of acetylcholinesterase (AchE) and inhibition of apoptosis were evaluated for each experimental group after treated with corresponding drugs simultaneously for 24 h. The relative expressions of TNF-α, caspase-3 and BDNF genes were also calculated and their effects on related genes were analyzed. Results: Compared to the model control group, the LPR-1 and LPR-2 administration groups zebrafishes showed prolonged total locomotor distance (highly significant, P<0.01), the differential speed of light and dark motion per minute (P<0.001) and the relative expression of BDNF gene (P<0.001) were significantly increased. Acetylcholinesterase (AchE) fluorescence values (extremely significant, P<0.001) and brain apoptotic cell fluorescence intensity (highly significant, P<0.01) were decreased, and the relative expression of TNF-α gene (highly significant, P<0.01) and caspase-3 gene (significant, P<0.05) were also decreased. Conclusion: Both of LPR-1 and LPR-2 have anti-Alzheimer's disease efficacy, and have potential for the development of functional foods for the prevention or treatment of Alzheimer's disease. |
| first_indexed | 2024-03-11T16:00:09Z |
| format | Article |
| id | doaj.art-9ccb3cd5da824855904f10ec24e226aa |
| institution | Directory Open Access Journal |
| issn | 1002-0306 |
| language | zho |
| last_indexed | 2024-03-11T16:00:09Z |
| publishDate | 2023-11-01 |
| publisher | The editorial department of Science and Technology of Food Industry |
| record_format | Article |
| series | Shipin gongye ke-ji |
| spelling | doaj.art-9ccb3cd5da824855904f10ec24e226aa2023-10-25T07:38:40ZzhoThe editorial department of Science and Technology of Food IndustryShipin gongye ke-ji1002-03062023-11-01442139540110.13386/j.issn1002-0306.20230100212023010021-21Effects of Royal Jelly Peptide on Motor Ability and Gene Expression in Zebrafish Model of Alzheimer's DiseaseJuncai LIU0Zhen GE1Xiao JIANG2Baojin CUI3Ping ZHANG4Jian'an SUN5Xiangzhao MAO6College of Food Science and Engineering, Ocean University of China, Qingdao 266003, ChinaCollege of Food Science and Engineering, Ocean University of China, Qingdao 266003, ChinaCollege of Medical, Qingdao Binhai University, Qingdao 266404, ChinaShandong Fengcai Health Industry Co., Ltd., Weifang 262612, ChinaShandong Fengcai Health Industry Co., Ltd., Weifang 262612, ChinaCollege of Food Science and Engineering, Ocean University of China, Qingdao 266003, ChinaCollege of Food Science and Engineering, Ocean University of China, Qingdao 266003, ChinaObjective: Investigation of the trait improvement impact of royal jelly enzymatic products (royal jelly peptides) on Alzheimer's disease (AD) model zebrafishes. Methods: 150 wild-type AB strain zebrafishes (4 days after fertilization, 4 dpf) were randomly divided into normal group, model control group, donepezil hydrochloride positive control group (3.33 μg/mL), royal jelly enzymatic digest lyophilized powder-1 group (LPR-1, 1000 μg/mL) and royal jelly enzymatic digest lyophilized powder-2 group (LPR-2, 1000 μg/mL), and these groups were added in 6-well plates, respectively. The volume of each well was 3 mL, and 30 tails of zebrafishes were employed in each group. Except for the normal group, zebrafishes in other groups were treated with aluminum chloride hexahydrate (180 μmol/L) to establish AD models. The efficacy of recovery of motor dysfunction, improvement of responsiveness, inhibition of acetylcholinesterase (AchE) and inhibition of apoptosis were evaluated for each experimental group after treated with corresponding drugs simultaneously for 24 h. The relative expressions of TNF-α, caspase-3 and BDNF genes were also calculated and their effects on related genes were analyzed. Results: Compared to the model control group, the LPR-1 and LPR-2 administration groups zebrafishes showed prolonged total locomotor distance (highly significant, P<0.01), the differential speed of light and dark motion per minute (P<0.001) and the relative expression of BDNF gene (P<0.001) were significantly increased. Acetylcholinesterase (AchE) fluorescence values (extremely significant, P<0.001) and brain apoptotic cell fluorescence intensity (highly significant, P<0.01) were decreased, and the relative expression of TNF-α gene (highly significant, P<0.01) and caspase-3 gene (significant, P<0.05) were also decreased. Conclusion: Both of LPR-1 and LPR-2 have anti-Alzheimer's disease efficacy, and have potential for the development of functional foods for the prevention or treatment of Alzheimer's disease.http://www.spgykj.com/cn/article/doi/10.13386/j.issn1002-0306.2023010021royal jelly peptidezebrafishalzheimer's diseasebehavioral analysismotor dysfunctionacetylcholinesterasebrain apoptosisrelative gene expression |
| spellingShingle | Juncai LIU Zhen GE Xiao JIANG Baojin CUI Ping ZHANG Jian'an SUN Xiangzhao MAO Effects of Royal Jelly Peptide on Motor Ability and Gene Expression in Zebrafish Model of Alzheimer's Disease Shipin gongye ke-ji royal jelly peptide zebrafish alzheimer's disease behavioral analysis motor dysfunction acetylcholinesterase brain apoptosis relative gene expression |
| title | Effects of Royal Jelly Peptide on Motor Ability and Gene Expression in Zebrafish Model of Alzheimer's Disease |
| title_full | Effects of Royal Jelly Peptide on Motor Ability and Gene Expression in Zebrafish Model of Alzheimer's Disease |
| title_fullStr | Effects of Royal Jelly Peptide on Motor Ability and Gene Expression in Zebrafish Model of Alzheimer's Disease |
| title_full_unstemmed | Effects of Royal Jelly Peptide on Motor Ability and Gene Expression in Zebrafish Model of Alzheimer's Disease |
| title_short | Effects of Royal Jelly Peptide on Motor Ability and Gene Expression in Zebrafish Model of Alzheimer's Disease |
| title_sort | effects of royal jelly peptide on motor ability and gene expression in zebrafish model of alzheimer s disease |
| topic | royal jelly peptide zebrafish alzheimer's disease behavioral analysis motor dysfunction acetylcholinesterase brain apoptosis relative gene expression |
| url | http://www.spgykj.com/cn/article/doi/10.13386/j.issn1002-0306.2023010021 |
| work_keys_str_mv | AT juncailiu effectsofroyaljellypeptideonmotorabilityandgeneexpressioninzebrafishmodelofalzheimersdisease AT zhenge effectsofroyaljellypeptideonmotorabilityandgeneexpressioninzebrafishmodelofalzheimersdisease AT xiaojiang effectsofroyaljellypeptideonmotorabilityandgeneexpressioninzebrafishmodelofalzheimersdisease AT baojincui effectsofroyaljellypeptideonmotorabilityandgeneexpressioninzebrafishmodelofalzheimersdisease AT pingzhang effectsofroyaljellypeptideonmotorabilityandgeneexpressioninzebrafishmodelofalzheimersdisease AT jianansun effectsofroyaljellypeptideonmotorabilityandgeneexpressioninzebrafishmodelofalzheimersdisease AT xiangzhaomao effectsofroyaljellypeptideonmotorabilityandgeneexpressioninzebrafishmodelofalzheimersdisease |